Microbiome venture can start production in Denmark and Switzerland
The Danish Medicines agency has inspected Bacthera, a joint venture between Danish enzyme giant Chr. Hansen and Swiss Lonza, and has authorized the company to start producing bacteria for medical purposes in Denmark. The Swiss health authorities have also given the go-ahead.
BY ALBERT RØNNING ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Bioscience company Chr. Hansen and Swiss biotech firm Lonza have obtained permission to launch the production of bacteria for pharmaceutical use in their production facilities in Denmark and Switzerland.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.